Internal Medicine · New York, NY
NPI
1114910890
Since 2005
Specialty
Internal Medicine
Code 207R00000X
Group practices
3
Medicare group memberships
Hospitals
2
Hospital affiliations
425 W 59th St, 4a
New York, NY, 10019
Phone (212) 489-8800
Groups this clinician bills Medicare through
Medicare paid, 2024
$379K
5,620 services
Medicare patients, 2024
631
Average age 85
Drug cost, 2024
$2.0M
34,038 prescriptions
Company payments, 2025
$508
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael E Rosen was code 99348 (home e&m - new and established), 1,052 times for 248 patients. In total Michael E Rosen billed 5,620 services in 29 codes, and Medicare paid $379K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-01-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99348 Home E&M - New and Established | Office | 1,052 | 248 | $61.89 | $65K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 876 | 298 | $48.68 | $43K |
| 99309 SNF E&M | Office | 836 | 148 | $79.86 | $67K |
| 99349 Home E&M - New and Established | Office | 747 | 277 | $99.36 | $74K |
| 99307 SNF E&M | Office | 737 | 121 | $28.58 | $21K |
| 99308 SNF E&M | Office | 400 | 119 | $56.90 | $23K |
| 99347 Home E&M - New and Established | Office | 244 | 123 | $34.85 | $8,503 |
| 99345 Home E&M - New and Established | Office | 162 | 162 | $152.82 | $25K |
| 99497 Care Management/Coordination | Office | 156 | 117 | $64.69 | $10K |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 130 | 84 | $42.14 | $5,479 |
| 99496 Chronic, Principal, and Transitional Care Management | Office | 80 | 72 | $231.22 | $18K |
| 99306 SNF E&M | Office | 48 | 46 | $139.95 | $6,717 |
| 99316 SNF E&M | Office | 31 | 31 | $101.01 | $3,131 |
| 99344 Home E&M - New and Established | Office | 26 | 26 | $90.87 | $2,362 |
| 96136 Behavioral Health Services | Office | 15 | 15 | $35.69 | $535 |
By year: 2022 $300K for 4,315 services; 2023 $335K for 4,791 services; 2024 $379K for 5,620 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michael E Rosen prescribed most often to Medicare patients was Atorvastatin Calcium, with 2,808 prescriptions and refills. In total Michael E Rosen wrote 34,038 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 2,808 | 2,872 | 305 | $30K |
| Amlodipine Besylate Generic | 1,591 | 1,679 | 193 | $9,611 |
| Levothyroxine Sodium Generic | 1,211 | 1,260 | 138 | $12K |
| Metoprolol Succinate Generic | 874 | 907 | 120 | $12K |
| Eliquis Apixaban | 809 | 827 | 117 | $373K |
| Mirtazapine Generic | 801 | 806 | 112 | $15K |
| Tamsulosin Hcl Generic | 780 | 824 | 113 | $11K |
| Losartan Potassium Generic | 776 | 797 | 112 | $7,883 |
| Omeprazole Generic | 704 | 724 | 89 | $6,201 |
| Metformin Hcl Generic | 676 | 717 | 77 | $5,640 |
| Furosemide Generic | 662 | 673 | 128 | $3,087 |
| Pantoprazole Sodium Generic | 580 | 600 | 105 | $6,010 |
| Gabapentin Generic | 542 | 554 | 85 | $5,523 |
| Famotidine Generic | 536 | 548 | 79 | $4,903 |
| Donepezil Hcl Generic | 487 | 525 | 78 | $5,374 |
Brand drugs: 4,109 claims; generic drugs: 29,677 claims; opioid claims: 347.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael E Rosen $508 ($508 in general payments such as food, travel and fees) from 1 company. The largest payer was Salix Pharmaceuticals, a division of Bausch Health US, LLC with $508.
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 31 | $508 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.